drugset / Trial / NCT02655198

Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy

NCT02655198

Phase 2 Unknown 13 enrolled KU Leuven Zogenix, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

In this trial, the potential anti-epileptic effect of low dose fenfluramine in Lennox Gastaut epilepsy will be studied. An exploratory dose finding add-on trial is proposed. At baseline and at the end of the study, ECG and ultrasound of the heart will be performed as part of the safety follow up.

Timeline

Start
2016-01
Primary completion
2018-09
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenfluramine Small molecule 0.2 mg/kg Oral
Subject Fenfluramine Small molecule 0.4 mg/kg Oral
Subject Fenfluramine Small molecule 0.8 mg/kg Oral